Tracey O’Brien, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, shared a post on LinkedIn:
“In NSW, people with cancer have once again shared how well cared for and supported they feel, in the latest Bureau of Health Information‘s (BHI) Outpatient Cancer Clinics Survey.
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant and Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group.
In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.
Overall care results are even better than last year, with 99 per cent of surveyed cancer patients rating their overall care as ‘very good’ or ‘good.’
This result is truly testament to the expert, passionate health professionals working in our outpatient settings. I cannot thank them enough for their commitment to people with cancer in NSW.
You can read more about the results on the Cancer Institute NSW website.”